Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies
AssigneeICOS Corporation
InventorsW. Michael Gallatin, Monica Van der Vieren
Life of this patent
Estimating the term…
Abstract
Methods to treat spinal cord injury using αd monoclonal antibodies are disclosed.
Claims9
A method for promoting locomotor recovery following spinal cord injury comprising the step of administering to a spinal cord injury victim an effective amount of an anti-αd monoclonal antibody.
A method for inhibiting locomotor damage following spinal cord injury comprising the step of administering to a spinal cord injury victim an effective amount of an anti-αd monoclonal antibody.
A method of limiting locomotor impairment following spinal cord injury comprising the step of administering to a spinal cord injury victim an effective amount of an anti-αd monoclonal antibody.
A method of limiting autonomic and sensory dysfunction following spinal cord injury comprising the step of administering to a spinal cord injury victim an effective amount of an anti-αd monoclonal antibody.
Dependencies are inferred from the claim text.